3-iodobenzylguanidine has been researched along with gallium ga 68 dotatate in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 9 (81.82) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Nahhas, A; Gishen, P; Lewington, V; Rubello, D; Todd, JF; Towey, D; Win, Z | 1 |
| Al-Nahhas, A; Ferrarese, A; Meades, R; Naji, M; Rubello, D; Tan, T; Welsh, SJ; Win, Z; Zhao, C | 1 |
| Al-Nahhas, A; Dhillo, W; Goldstone, AP; Martin, NM; Maurice, JB; Meeran, K; Naji, M; Palazzo, F; Ramachandran, R; Tan, T; Todd, JF; Troke, R; Win, Z | 1 |
| Cuccurullo, V; Mansi, L | 1 |
| Agrawal, K; Bomanji, J; Gavra, M; Sajjan, RS; Syed, R | 1 |
| Hassan, SZ; Lee, BN; Tan, TH; Wong, TH | 1 |
| Downie, P; Eu, P; Hicks, RJ; Hofman, MS; Hogg, A; Kong, G; Murray, WK; Super, L; Wilson, S; Wood, P | 1 |
| Huo, L; Jing, H; Li, F; Li, W; Wang, L; Wang, Z; Zhang, J | 1 |
| Ahmadzadehfar, H; Alexander, N; Baruchel, S; Shammas, A; Vali, R | 1 |
| Ballinger, JR | 1 |
| Parra, LA; Salomao, MA; Swanson, SK; Yang, M | 1 |
2 review(s) available for 3-iodobenzylguanidine and gallium ga 68 dotatate
| Article | Year |
|---|---|
Review: The Role of Radiolabeled DOTA-Conjugated Peptides for Imaging and Treatment of Childhood Neuroblastoma.
Topics: 3-Iodobenzylguanidine; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Neuroblastoma; Octreotide; Organometallic Compounds; Positron Emission Tomography Computed Tomography | 2018 |
Theranostic radiopharmaceuticals: established agents in current use.
Topics: 3-Iodobenzylguanidine; Antigens, CD20; Bone Neoplasms; Dipeptides; Diphosphonates; Drug Approval; Forecasting; Heterocyclic Compounds, 1-Ring; Hodgkin Disease; Humans; Iodine Radioisotopes; Lutetium; Octreotide; Organometallic Compounds; Prostate-Specific Antigen; Radiopharmaceuticals; Somatostatin; Theranostic Nanomedicine; Thyroid Diseases | 2018 |
9 other study(ies) available for 3-iodobenzylguanidine and gallium ga 68 dotatate
| Article | Year |
|---|---|
68Ga-DOTATATE PET in neuroectodermal tumours: first experience.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Female; Humans; Image Enhancement; Male; Middle Aged; Organometallic Compounds; Pheochromocytoma; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
68Ga-DOTA-TATE PET vs. 123I-MIBG in identifying malignant neural crest tumours.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Female; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Mutation; Organometallic Compounds; Paraganglioma; Positron-Emission Tomography; Retrospective Studies; Succinate Dehydrogenase; Young Adult | 2011 |
A comparison of the performance of ⁶⁸Ga-DOTATATE PET/CT and ¹²³I-MIBG SPECT in the diagnosis and follow-up of phaeochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Follow-Up Studies; Humans; Middle Aged; Multimodal Imaging; Organometallic Compounds; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Young Adult | 2012 |
Toward tailored medicine (and beyond): the phaeochromocytoma and paraganglioma model.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Humans; Multimodal Imaging; Organometallic Compounds; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2012 |
68Ga-DOTATATE PET/MR Imaging of Urinary Bladder Paraganglioma.
Topics: 3-Iodobenzylguanidine; Adolescent; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Organometallic Compounds; Paraganglioma; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2015 |
Unusual Bone Superscan, MIBG Superscan, and 68Ga DOTATATE PET/CT in Metastatic Pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Bone Neoplasms; Humans; Male; Multimodal Imaging; Organometallic Compounds; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Initial Experience With Gallium-68 DOTA-Octreotate PET/CT and Peptide Receptor Radionuclide Therapy for Pediatric Patients With Refractory Metastatic Neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child; Child, Preschool; Female; Humans; Immunohistochemistry; Male; Multimodal Imaging; Neuroblastoma; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Retrospective Studies; Tomography, X-Ray Computed | 2016 |
Comparison of the 68Ga-DOTATATA PET/CT, FDG PET/CT, and MIBG SPECT/CT in the Evaluation of Suspected Primary Pheochromocytomas and Paragangliomas.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Organometallic Compounds; Paraganglioma; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Retrospective Studies; Single Photon Emission Computed Tomography Computed Tomography | 2017 |
Multifocal Urinary Bladder Paragangliomas With Negative 68Ga-DOTATATE Uptake and Positive 123I-MIBG Uptake.
Topics: 3-Iodobenzylguanidine; Biological Transport; Humans; Male; Middle Aged; Organometallic Compounds; Paraganglioma; Positron Emission Tomography Computed Tomography; Receptors, Somatostatin; Urinary Bladder Neoplasms | 2020 |